Ashfield Capital Partners, LLC 9 Meters Biopharma, Inc. Transaction History

Ashfield Capital Partners, LLC

  • $1.19 Billion
  • Q3 2022

A detailed history of Ashfield Capital Partners, LLC transactions in 9 Meters Biopharma, Inc. stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 33,353 shares of NMTR stock, worth $667. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,353
Previous 33,353 -0.0%
Holding current value
$667
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 05, 2020
BUY
$0.43 - $0.74 $14,341 - $24,681
33,353 New
33,353 $19,000

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Ashfield Capital Partners, LLC Portfolio

Follow Ashfield Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email